198 related articles for article (PubMed ID: 33559345)
1. Camptothecin and Topotecan, Inhibitors of Transcription Factor Fli-1 and Topoisomerase, Markedly Ameliorate Lupus Nephritis in (NZB × NZW)F1 Mice and Reduce the Production of Inflammatory Mediators in Human Renal Cells.
Wang X; Oates JC; Helke KL; Gilkeson GS; Zhang XK
Arthritis Rheumatol; 2021 Aug; 73(8):1478-1488. PubMed ID: 33559345
[TBL] [Abstract][Full Text] [Related]
2. Effective therapy for nephritis in (NZB x NZW)F1 mice with triptolide and tripdiolide, the principal active components of the Chinese herbal remedy Tripterygium wilfordii Hook F.
Tao X; Fan F; Hoffmann V; Gao CY; Longo NS; Zerfas P; Lipsky PE
Arthritis Rheum; 2008 Jun; 58(6):1774-83. PubMed ID: 18512813
[TBL] [Abstract][Full Text] [Related]
3. Relationship of DNA damage signaling to DNA replication following treatment with DNA topoisomerase inhibitors camptothecin/topotecan, mitoxantrone, or etoposide.
Zhao H; Rybak P; Dobrucki J; Traganos F; Darzynkiewicz Z
Cytometry A; 2012 Jan; 81(1):45-51. PubMed ID: 22140093
[TBL] [Abstract][Full Text] [Related]
4. Low-dose irinotecan improves advanced lupus nephritis in mice potentially by changing DNA relaxation and anti-double-stranded DNA binding.
Frese-Schaper M; Keil A; Steiner SK; Gugger M; Körner M; Kocher GJ; Schiffer L; Anders HJ; Huynh-Do U; Schmid RA; Frese S
Arthritis Rheumatol; 2014 Aug; 66(8):2259-69. PubMed ID: 24729466
[TBL] [Abstract][Full Text] [Related]
5. Cytoskeletal interference - A new mode of action for the anticancer drugs camptothecin and topotecan.
Wang X; Tanaka M; Krstin S; Peixoto HS; Moura CCM; Wink M
Eur J Pharmacol; 2016 Oct; 789():265-274. PubMed ID: 27474470
[TBL] [Abstract][Full Text] [Related]
6. Impact of Fli-1 transcription factor on autoantibody and lupus nephritis in NZM2410 mice.
Mathenia J; Reyes-Cortes E; Williams S; Molano I; Ruiz P; Watson DK; Gilkeson GS; Zhang XK
Clin Exp Immunol; 2010 Nov; 162(2):362-71. PubMed ID: 20731671
[TBL] [Abstract][Full Text] [Related]
7. Suppression of lupus nephritis and skin lesions in MRL/lpr mice by administration of the topoisomerase I inhibitor irinotecan.
Keil A; Hall SR; Körner M; Herrmann M; Schmid RA; Frese S
Arthritis Res Ther; 2016 Oct; 18(1):243. PubMed ID: 27770825
[TBL] [Abstract][Full Text] [Related]
8. HSPB5 suppresses renal inflammation and protects lupus-prone NZB/W F1 mice from severe renal damage.
Knapp J; Braunstein M; Berg SIT; Shirriff C
Arthritis Res Ther; 2022 Dec; 24(1):267. PubMed ID: 36510250
[TBL] [Abstract][Full Text] [Related]
9. Cellular pharmacokinetics and cytotoxicity of camptothecin and topotecan at normal and acidic pH.
Gabr A; Kuin A; Aalders M; El-Gawly H; Smets LA
Cancer Res; 1997 Nov; 57(21):4811-6. PubMed ID: 9354443
[TBL] [Abstract][Full Text] [Related]
10. Reduced fragmentation of apoptotic chromatin is associated with nephritis in lupus-prone (NZB x NZW)F(1) mice.
Zykova SN; Seredkina N; Benjaminsen J; Rekvig OP
Arthritis Rheum; 2008 Mar; 58(3):813-25. PubMed ID: 18311834
[TBL] [Abstract][Full Text] [Related]
11. The Topoisomerase I Inhibitor Irinotecan and the Tyrosyl-DNA Phosphodiesterase 1 Inhibitor Furamidine Synergistically Suppress Murine Lupus Nephritis.
Keil A; Frese-Schaper M; Steiner SK; Körner M; Schmid RA; Frese S
Arthritis Rheumatol; 2015 Jul; 67(7):1858-67. PubMed ID: 25779651
[TBL] [Abstract][Full Text] [Related]
12. The role of aldosterone blockade in murine lupus nephritis.
Monrad SU; Killen PD; Anderson MR; Bradke A; Kaplan MJ
Arthritis Res Ther; 2008; 10(1):R5. PubMed ID: 18197980
[TBL] [Abstract][Full Text] [Related]
13. Atializumab, a humanized anti-aminoacyl-tRNA synthetase-interacting multifunctional protein-1 (AIMP1) antibody significantly improves nephritis in (NZB/NZW) F1 mice.
Mun CH; Kim JO; Ahn SS; Yoon T; Kim SJ; Ko E; Noh HD; Park YB; Jung HJ; Kim TS; Lee SW; Park SG
Biomaterials; 2019 Nov; 220():119408. PubMed ID: 31394431
[TBL] [Abstract][Full Text] [Related]
14. Reversal of established lupus nephritis and prolonged survival of New Zealand black x New Zealand white mice treated with the topoisomerase I inhibitor irinotecan.
Frese-Schaper M; Zbaeren J; Gugger M; Monestier M; Frese S
J Immunol; 2010 Feb; 184(4):2175-82. PubMed ID: 20083657
[TBL] [Abstract][Full Text] [Related]
15. Anti-DNA antibody induction of protein kinase C phosphorylation and fibronectin synthesis in human and murine lupus and the effect of mycophenolic acid.
Yung S; Zhang Q; Zhang CZ; Chan KW; Lui SL; Chan TM
Arthritis Rheum; 2009 Jul; 60(7):2071-82. PubMed ID: 19565476
[TBL] [Abstract][Full Text] [Related]
16. Antiangiogenic potential of camptothecin and topotecan.
Clements MK; Jones CB; Cumming M; Daoud SS
Cancer Chemother Pharmacol; 1999; 44(5):411-6. PubMed ID: 10501915
[TBL] [Abstract][Full Text] [Related]
17. Intranuclear delivery of the transcription modulation domain of Tbet-improved lupus nephritis in (NZB/NZW) F1 lupus-prone mice.
Moon JS; Mun CH; Kim JH; Cho JY; Park SD; Park TY; Shin JS; Ho CC; Park YB; Ghosh S; Bothwell ALM; Lee SW; Lee SK
Kidney Int; 2018 May; 93(5):1118-1130. PubMed ID: 29409726
[TBL] [Abstract][Full Text] [Related]
18. Effect of an exogenous trigger on the pathogenesis of lupus in (NZB x NZW)F1 mice.
Yoshida H; Satoh M; Behney KM; Lee CG; Richards HB; Shaheen VM; Yang JQ; Singh RR; Reeves WH
Arthritis Rheum; 2002 Aug; 46(8):2235-44. PubMed ID: 12209530
[TBL] [Abstract][Full Text] [Related]
19. CXCR3 promotes the production of IgG1 autoantibodies but is not essential for the development of lupus nephritis in NZB/NZW mice.
Moser K; Kalies K; Szyska M; Humrich JY; Amann K; Manz RA
Arthritis Rheum; 2012 Apr; 64(4):1237-46. PubMed ID: 22006377
[TBL] [Abstract][Full Text] [Related]
20. Tuftsin-phosphorylcholine (TPC) equally effective to methylprednisolone in ameliorating lupus nephritis in a mice model.
Shemer A; Kivity S; Shovman O; Bashi T; Perry O; Watad A; Ben-Ami Shor D; Volkov A; Barshack I; Bragazzi NL; Krule A; Fridkin M; Amital H; Blank M; Shoenfeld Y
Clin Exp Immunol; 2018 Aug; 193(2):160-166. PubMed ID: 29698559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
